WAT
NYSEWATERS CORP /DE/
Health Care, Life Sciences Tools & Services
$406.86
close 7 Aug 2026
+45.68%
52-week change
$39.94B
market cap
$278.49
$414.15
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $3.77B | $3.17B | $2.96B | $2.96B | $2.97B | $2.79B | $2.37B | $2.41B | $2.42B | $2.31B | $2.17B | $2.04B | $1.99B | $1.90B | $1.84B | $1.85B | $1.64B | $1.50B | $1.58B | $1.47B |
| Cost of revenue | — | $1.29B | $1.20B | $1.20B | $1.25B | $1.16B | $1.01B | $1.01B | $992.56M | $947.07M | $891.45M | $565.63M | $549.12M | $783.46M | $737.61M | $730.49M | $653.30M | $594.88M | $661.27M | $631.12M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | $1.20B | $1.16B | $1.12B | $1.11B | $1.12B | $990.07M | $903.82M | $913.86M | $841.93M |
| R&D | $245.09M | $195.71M | $183.03M | $174.95M | $176.19M | $168.36M | $140.78M | $142.96M | $143.40M | $132.59M | $125.19M | $118.55M | $107.73M | $100.54M | $96.00M | $92.35M | $84.27M | $77.15M | $81.59M | $80.65M |
| SG&A | $1.04B | $830.37M | $690.15M | $736.01M | $658.03M | $626.97M | $553.70M | $534.79M | $536.90M | $544.36M | $512.33M | $495.75M | $512.71M | $492.97M | $477.27M | $490.01M | $445.46M | $421.40M | $426.70M | $403.70M |
| Operating income | $603.84M | $802.59M | $826.35M | $817.68M | $873.40M | $821.71M | $645.49M | $708.46M | $739.77M | $662.20M | $625.04M | $567.45M | $517.91M | $517.34M | $511.49M | $528.60M | $449.93M | $394.60M | $389.75M | $348.88M |
| Interest expense | $103.28M | $69.55M | $89.68M | $98.86M | $48.80M | $44.94M | $49.07M | $48.69M | $48.64M | $56.84M | $44.91M | $36.24M | $34.19M | $30.05M | $28.07M | $21.97M | $13.92M | $10.99M | $38.52M | -$56.52M |
| Tax expense | $74.74M | $112.25M | $117.03M | $94.01M | $130.09M | $113.35M | $89.34M | $86.04M | $88.35M | $620.79M | $78.61M | $72.87M | $59.12M | $40.10M | $26.18M | $76.28M | $56.10M | $63.34M | $49.71M | $55.12M |
| Net income | $449.25M | $642.63M | $637.83M | $642.23M | $707.76M | $692.84M | $521.57M | $592.20M | $593.79M | $20.31M | $521.50M | $469.05M | $431.62M | $450.00M | $461.44M | $432.97M | $381.76M | $323.31M | $322.48M | $268.07M |
| Diluted EPS | $7.87 | $10.76 | $10.71 | $10.84 | $11.73 | $11.17 | $8.36 | $8.69 | $7.65 | $0.2500 | $6.41 | $5.65 | $5.07 | $5.20 | $5.19 | $4.69 | $4.06 | $3.34 | $3.21 | $2.62 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | 58.74% | 58.53% | 58.86% | 59.99% | 60.54% | 60.25% | 60.31% | 58.02% | 57.16% |
| Operating margin | 16.01% | 25.36% | 27.93% | 27.66% | 29.39% | 29.50% | 27.29% | 29.44% | 30.57% | 28.68% | 28.84% | 27.78% | 26.03% | 27.17% | 27.74% | 28.55% | 27.38% | 26.33% | 24.74% | 23.68% |
| Net margin | 11.91% | 20.30% | 21.56% | 21.72% | 23.81% | 24.87% | 22.05% | 24.61% | 24.54% | 0.88% | 24.06% | 22.97% | 21.70% | 23.63% | 25.03% | 23.39% | 23.23% | 21.57% | 20.47% | 18.20% |
filed 12 May 2026